Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021;19(7):1069-1089.
doi: 10.2174/1570159X18666201015161919.

Peripheral and Central Glutamate Dyshomeostasis in Neurodegenerative Disorders

Adejoke Y Onaolapo  1 , Olakunle J Onaolapo  2
Affiliations

Peripheral and Central Glutamate Dyshomeostasis in Neurodegenerative Disorders

Adejoke Y Onaolapo et al. Curr Neuropharmacol. 2021.

Abstract

Glutamate's role as the major excitatory neurotransmitter of the mammalian central nervous system requires that its brain concentrations be kept tightly-controlled. However, in hepatic encephalopathy resulting from liver dysfunction; disruption of central neurotransmission and elevation of brain glutamate levels have been observed. These had been associated with certain neurological changes. While neurological changes resulting from hepatic encephalopathy are believed to be transient, the discovery of alterations in liver enzymes in Alzheimer's disease and the role of glutamate and glutamate homeostasis in hepatic encephalopathy have piqued interests in the possible role of glutamate, and glutamate homeostasis in neurodegenerative diseases. Here, we discuss the evidence in support of the involvement of peripheral/central glutamate homeostasis in the development of neurodegenerative disorders, as well as, the implications of such interactions in the development of new therapies for neurodegenerative disorders.

Keywords: Gut-liver brain axis; cystine-glutamate antiporter.; glutamate receptors; sodium-dependent transporter.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. McKenna M., Dienel G.A., Sonnewald U., Waagepetersen H.S., Schousboe A. In: Energy metabolism of the brain.Basic Neurochmistry; Brady, S.T.; Siegel, G.J.; Albers, R.W. Price D.I., editor. Waltham, MS, USA: Academic Press, Elsevier; - DOI
    1. Schousboe A., Scafidi S., Bak L.K., Waagepetersen H.S., McKenna M.C. Glutamate metabolism in the brain focusing on astrocytes. Adv. Neurobiol. 2014;11:13–30. doi: 10.1007/978-3-319-08894-5_2. - DOI - PMC - PubMed
    1. Onaolapo O.J., Onaolapo A.Y., Akanmu M.A., Gbola O. Evidence of alterations in brain structure and antioxidant status following ‘low-dose’ monosodium glutamate ingestion. Pathophysiology. 2016;23(3):147–156. doi: 10.1016/j.pathophys.2016.05.001. - DOI - PubMed
    1. Onaolapo A.Y., Odetunde I., Akintola A.S., Ogundeji M.O., Ajao A., Obelawo A.Y., Onaolapo O.J. Dietary composition modulates impact of food-added monosodium glutamate on behaviour, metabolic status and cerebral cortical morphology in mice. Biomed. Pharmacother. 2019;109:417–428. doi: 10.1016/j.biopha.2018.10.172. - DOI - PubMed
    1. Onaolapo A.Y., Olawore O.I., Yusuf F.O., Adeyemo A.M., Adewole I.O., Onaolapo O.J. Oral monosodium glutamate administration differentially affects novelty induced behaviours, behavioural despair and place preference in male and female mice. Curr. Psychopharmacol. 2019:8. doi: 10.2174/2211556008666181213160527. - DOI